Spike proteins cover the surface of the SARS-CoV-2 virus, giving it its crown ("corona") aspect. These spikes bind to human cells in order to infect them. The spikes themselves do not cause the ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.